ZEVEX INTERNATIONAL INC
SC 13D/A, 1999-07-16
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: MEDICAL TECHNOLOGY SYSTEMS INC /DE/, 8-K, 1999-07-16
Next: ZEVEX INTERNATIONAL INC, SC 13D/A, 1999-07-16



                                            ------------------------------------
                                                         OMB APPROVAL
                                            ------------------------------------
                                              OMB Number:              3235-0145
                                              Expires:         December 31, 1997
                                              Estimated average burden
                                                hours to perform.......... 14.90
                                            ------------------------------------

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                 SCHEDULE 13D/A
                    Under the Securities Exchange Act of 1934
                                (AMENDMENT NO. 1)


                            ZEVEX INTERNATIONAL, INC.
                         ------------------------------
                                (Name of Issuer)

                                  Common Stock
                         ------------------------------
                         (Title of Class of Securities)


                                    98950E400
                                 --------------
                                 (CUSIP Number)


                           Christian J. Hoffmann, III
                               STREICH LANG, P.A.
                                 Renaissance One
                            Two North Central Avenue
                           Phoenix, Arizona 85004-2391
                                 (602) 229-5200
            --------------------------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                                 May 30, 1999
             -------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  which is the subject of this  Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].

NOTE: Six copies of this statement, including all exhibits, should be filed with
the  Commission.  See Rule  13d-1(a) for other  parties to whom copies are to be
sent.

* The remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).
<PAGE>
                                 SCHEDULE 13D/A
                                (AMENDMENT NO. 1)

- -------------------                                            -----------------
CUSIP NO. 98950E400                                            PAGE 2 OF 5 PAGES
- -------------------                                            -----------------

1   NAMES OF REPORTING PERSON
    S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    JEFF HOLMES
    ----------------------------------------------------------------------------
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                    (a) [X]
                                                                         (b) [ ]
    ----------------------------------------------------------------------------
3   SEC USE ONLY

    ----------------------------------------------------------------------------
4   SOURCE OF FUNDS*


    ----------------------------------------------------------------------------
5   CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
    TO ITEMS 2(d) OR 2(e)                                                    [ ]

    ----------------------------------------------------------------------------
6   CITZENSHIP OR PLACE OF ORGANIZATION

    United States
    ----------------------------------------------------------------------------
                  7  SOLE VOTING POWER
                     125,000 shares of common stock
     NUMBER OF       -----------------------------------------------------------
      SHARES      8  SHARED VOTING POWER
    BENEFICIALLY     250,000 shares of common stock, see Items 3 and 5
     OWNED BY        -----------------------------------------------------------
       EACH       9  SOLE DISPOSITIVE POWER
     REPORTING       125,000 shares of common stock
      PERSON         -----------------------------------------------------------
       WITH      10  SHARED DISPOSITIVE POWER
                     250,000 shares of common stock, see Items 3 and 5
                     -----------------------------------------------------------
11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    375,000
    ----------------------------------------------------------------------------
12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*   [ ]


    ----------------------------------------------------------------------------
13  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

    11.0% (As of April 15, 1999)
    ----------------------------------------------------------------------------
14  TYPE OF REPORTING PERSON*

    IN
    ----------------------------------------------------------------------------
                      *SEE INSTRUCTIONS BEFORE FILLING OUT!
          INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
      (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
                                 SCHEDULE 13D/A
                                (AMENDMENT NO. 1)

- -------------------                                            -----------------
CUSIP NO. 98950E400                                            PAGE 3 OF 5 PAGES
- -------------------                                            -----------------

ITEM 1. SECURITY AND ISSUER

          This   statement   relates   to  shares  of  Common   Stock  of  Zevex
     International,  Inc. (the "Issuer")  whose address is 4314 Zevex Park Lane,
     Salt Lake City, Utah 84123.

ITEM 2. IDENTITY AND BACKGROUND

          (a) The individual filing this statement is Jeff Holmes;

          (b) Mr. Holmes'  business  address is 4314 Zevex Park Lane,  Salt Lake
     City, Utah 84123.

          (c) Mr.  Holmes is self  employed  principally  involved  in  business
     consulting;

          (d) Mr. Holmes has not, during the past five years,  been convicted in
     a criminal proceeding.

          (e) Mr. Holmes has not, during the past five years,  been a party to a
     civil  proceeding  of  a  judicial  or  administrative  body  of  competent
     jurisdiction which resulted in a judgment,  decree or final order enjoining
     future  violations of, or prohibiting or mandating  activities  subject to,
     federal or state  securities  laws or finding any violation with respect to
     such laws.

          (f) Mr. Holmes is a citizen of the United States.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION

          This Amendment No. 1 to Schedule 13D is being filed to report the sale
     of 175,000  warrants to purchase  common  stock of the Issuer to the Issuer
     pursuant to a Warrant and Stock Purchase  Agreement dated May 25, 1999 (the
     "Purchase Agreement").

ITEM 4. PURPOSE OF TRANSACTION

          This Amendment No. 1 to Schedule 13D is being filed to report the sale
     of 175,000 warrants to purchase common stock of the Issuer.

          Except as set forth the Purchase Agreement described in Items 3 and 6,
     the  Reporting  Person has no plans or  proposal  that  related to or would
     result in any of the actions specified in clauses (a) through (j) of Item 4
     of Schedule 13D.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER

          (a) As of May 30, 1999, Mr. Holmes  beneficially  owned 125,000 shares
     of the Issuer  representing 3.7% of the Issuer's  outstanding  common stock
     (utilizing  the shares  listed as  outstanding  on April 15,  1999 from the
     Issuer's  Definitive  Proxy  Statement  as filed  with the  Securities  and
     Exchange  Commission on May 5, 1999).  Additionally,  Mr.  Holmes,  through
     Blosch and Holmes,  LLC,  beneficially owns an additional 250,000 shares of
     the  Issuer's  common  stock  bringing  the total  number  of shares  owned
     directly  and  beneficially  to  375,000  share  representing  11.0% of the
     Issuer's common stock.

          (b) Mr.  Holmes  has  sole  power to vote the  125,000  shares  of the
     Issuer's common stock held in his name and shared power to vote the 250,000
     shares in the name of Blosch and Holmes, LLC.

          (c) Other than the sale of the 175,000 warrants reported hereunder and
     the agreement  discussed in Item 6 below, Mr. Holmes has not engaged in any
     transaction involving the Issuer's securities.
<PAGE>
                                 SCHEDULE 13D/A
                                (AMENDMENT NO. 1)

- -------------------                                            -----------------
CUSIP NO. 98950E400                                            PAGE 4 OF 5 PAGES
- -------------------                                            -----------------

          (d) Mr.  Holmes has the sole right to receive  and the power to direct
     the receipt of dividends from, or the proceeds from the sale of the 125,000
     shares he holds and shares power with Kirk Blosch in regards to the 250,000
     shares held by Blosch and Holmes, LLC.

ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
        SECURITIES OF THE ISSUER.

          Mr.  Holmes,  Kirk  Blosch and Blosch and  Holmes,  LLC,  of which Mr.
     Holmes is a member, are parties to the Purchase Agreement pursuant to which
     the Issuer  has  agreed to use its  reasonable  best  efforts  to  identify
     prospective  purchasers  for the cash  purchase  of the shares  held by Mr.
     Holmes, Kirk Blosch and by Blosch and Holmes, LLC.

ITEM 7. MATERIALS TO BE FILED AS EXHIBITS

          The Purchase  Agreement  between Mr. Holmes,  Kirk Blosch,  Blosch and
     Holmes, LLC and the Issuer is attached hereto as Exhibit 1.
<PAGE>
                                 SCHEDULE 13D/A
                                (AMENDMENT NO. 1)

- -------------------                                            -----------------
CUSIP NO. 98950E400                                            PAGE 5 OF 5 PAGES
- -------------------                                            -----------------

                                  SIGNATURE

     After  reasonable  inquiry and to the best of my  knowledge  and belief,  I
certify that the information  set forth in this statement is true,  complete and
correct.


7/14/99                                       /s/ Jeff Holmes
- -----------------------                       ----------------------------------
Date                                          Signature

                                              Jeff Holmes
                                              ----------------------------------
                                              Name

            ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT
          CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)

                      WARRANT AND STOCK PURCHASE AGREEMENT


     This Warrant and Stock Purchase  Agreement  (this  "Agreement") is made and
entered into as of the ____ day of _________________, 1999, by and between ZEVEX
International,  Inc., a Delaware  corporation  ("Purchaser"),  Kirk  Blosch,  an
individual resident in the State of Utah, Jeff W. Holmes, an individual resident
in the State of Nevada,  and  Blosch & Holmes,  LLC,  a Utah  limited  liability
company (each a "Seller" and collectively,  the "Sellers"). All of the foregoing
collectively referred to as the "Parties."

                                   WITNESSETH:

     WHEREAS,  each  Seller owns a warrant or  warrants  (each a  "Warrant"  and
collectively,  the  "Warrants")  entitling  such Seller to purchase  that number
shares of Common Stock of the  Purchaser,  set forth opposite such Seller's name
in Exhibit A (collectively, the "Warrant Stock");

     WHEREAS,  Sellers own that  number of shams of Common  Stock of the Company
set forth opposite such Seller's name in Exhibit A (collectively, the "Shares");

     WHEREAS,  Sellers desire to sell the Warrants to the Purchaser, and for the
Purchaser  to introduce  third  parties to purchase the Shares from the Sellers,
pursuant to the terms and conditions contained herein;

     WHEREAS, the purchase price for the Warrants will be based on the number of
Shares  purchasable  thereunder  multiplied by $2.50 (that being the  difference
between the exercise  price of $3.50 under the Warrants and $6.00,  the "Warrant
Purchase  Price"),  and the  purchase  price for the Shares will be $6 per share
(the  "Share   Purchase   Price"),   as  more  fully   described  in  Exhibit  A
(collectively, the "Purchase Price");

     NOW  THEREFORE,  in  consideration  of the  mutual  covenants,  agreements,
conditions,  representations,  and warranties  contained in this Agreement,  the
Purchaser and each Seller hereby agree as follows:

1. PURCHASE AND SALE OF WARRANTS AND SHARES.

     1.1  PURCHASE AND SALE OF WARRANTS.

          (a)  Subject to the terms and  conditions  of this  Agreement,  at the
first Closing (as defined below), each Seller hereby agrees to sell to Purchaser
and the Purchaser hereby agrees to purchase from each Seller,  all right,  title
and interest in and to the Warrants in  consideration  for the Warrant  Purchase
Price.

          (b)  Subject to all the terms and  conditions  of this  Agreement,  in
payment for the  Warrants,  Purchaser  shall deliver to each Seller at the First
Closing, by means of a bank wire transfer, cashier's check, or other immediately
available funds, the amount indicated on Exhibit A set opposite the name of each
Seller. This consideration shall be payment in full for all of the Warrants.

          (c) The Purchase and sale of the Warrants shall be held at the offices
of the Purchaser  within two business days of the execution  hereof,  or at such
other place,  time, and date as Sellers and Purchaser shall mutually agree (this
event  is  hereafter  referred  to as the  "First  Closing"  and the date of the
Closing is  hereafter  referred to as the "First  Closing  Date").  At the First
Closing, the
<PAGE>
Sellers shall deliver to Purchaser, the certificates  representing the Warrants,
and Purchaser shall deliver to the Sellers the Warrant Purchase Price.

     1.2 PURCHASE OF  ADDITIONAL  WARRANTS.  Within ten (10) days  following the
execution  of this  Agreement,  the  Purchaser  shall make a tender offer to all
holders of warrants of Common Stock in the Purchaser who are not parties to this
Agreement.  The offer  shall be to  purchase  all such  warrants  at the Warrant
Purchase  Price,  with a closing thereon to occur within 14 calendar days of the
execution hereof.

     1.3 PURCHASE AND SALE OF SHARES. For a period of 21 days from the execution
hereof  the  Purchaser  shall  use  its  reasonable  best  efforts  to  identify
prospective  purchasers  for  the  cash  purchase  of  the  Shares  (the  "Share
Purchasers") at the Share Purchase Price. In the event that Share Purchasers are
identified  who are prepared to purchase less than all of the Shares,  then each
Seller  shall have the right to sell its pro rata  portion of the Shares to such
Share Purchasers. Each Seller covenants and agrees that it shall sell its Shares
(or pro rata  portion  thereof)  in the event  that a Share  Purchaser  or Share
Purchasers  are  prepared  to purchase  such Shares (or portion  thereof) at the
Share Purchase Price.  The Sellers and the Share  Purchasers  shall enter into a
definitive  purchase  agreement for the purchase of the Shares,  which agreement
shall be in form and  Substance  satisfactory  to the Purchaser and each Seller.
Consummation  of the purchase of the Shares shall occur on one or more occasions
between the date of  execution  hereof and that date which is 21  calendar  days
from the date of execution hereof (the "Subsequent Closing").

2. REPRESENTATIONS AND WARRANTIES OF THE SELLER.

     Each of the Sellers  hereby  represents  and warrants to the Purchaser that
the  statements  contained  in this Section 2 are correct and complete as of the
date of this Agreement and shall be correct and complete as of the First Closing
Date and as of the  Subsequent  Closing  with  respect to himself or itself,  as
follows:

     2.1  AUTHORIZATION OF TRANSACTIONS.  Seller has full power and authority to
execute  and  deliver  this  Agreement  and to  perform  his or her  obligations
hereunder.  This Agreement  constitutes the valid and legally binding obligation
of the Seller,  enforceable in accordance with its terms and conditions.  Seller
need not give any notice to, make any filing with, or obtain, any authorization,
consent,  or  approval  of any  government  or  governmental  agency in order to
consummate the transactions contemplated by this Agreement.

     2.2  NONCONTRAVENTION.  Neither  the  execution  and the  delivery  of this
Agreement,  nor the consummation of the transactions  contemplated  hereby, will
(a) violate any constitution,  statute, regulation, rule, injunction,  judgment,
order,  decree,   ruling,  charge,  or  other  restriction  of  any  government,
governmental  agency,  or court to which the Seller is subject or, (b)  conflict
with,  result  in a  breach  of,  constitute  a  default  under,  result  in the
acceleration of, create in any party the right to accelerate, terminate, modify,
or cancel, or require any notice under any agreement,  contract, lease, license,
instrument,  or other  arrangement to which the Seller is a party or by which he
or she is bound or to which any of his or her assets is subject.

     2.3 WARRANTS AND SHARES.  The Seller holds of record and owns  beneficially
the  Warrants  for the number of shares of common  stock  purchasable  under the
Warrants,  and the number of Shares,  set forth  opposite  such Seller's name in
Exhibit  A,  free  and  clear  of  any  restrictions  on  transfer  (other  than
restrictions  under  the  Securities  Act and  state  securities  laws),  taxes,
security interests, purchase rights, contracts,  commitments,  equities, claims,
liens,  charges,  pledges,  encumbrances  and  demands  of any  kind  or  nature
whatsoever. The Seller is not a party to any option, warrant, purchase right, or

                                       -2-
<PAGE>
other contract or commitment that could require the Seller to sell, transfer, or
otherwise  dispose of the Warrants and/or the common stock purchasable under the
Warrants and/or the Shares (other than this Agreement).

3. REPRESENTATIONS AND WARRANTIES OF THE PURCHASER.

     The Purchaser  represents and warrants to the Sellers that the,  statements
contained  in this  Section 3 are correct and complete as of the date hereof and
will be correct and  complete as of the First  Closing  Date and the  Subsequent
Closing, as follows:

     3.1  AUTHORITY.  The Purchaser is a  corporation  duly  organized,  validly
existing  and in good  standing  under  the laws of the State of  Delaware.  The
Purchaser  has all  requisite  corporate  power and authority to enter into this
Agreement and to consummate the  transactions  contemplated  hereby and thereby.
All corporate acts and other  proceedings  required to be taken by the Purchaser
to authorize the execution,  delivery and  performance of this Agreement and the
consummation of the transactions  contemplated hereby and thereby have been duly
and properly  taken.  This Agreement has been duly executed and delivered by the
Purchaser  and  constitutes  a valid and binding  obligation  of the  Purchaser,
enforceable against the Purchaser in accordance with its terms.

     3.2  NONCONTRAVENTION.  Neither  the  execution  and the  delivery  of this
Agreement,  nor the consummation of the transactions  contemplated  hereby, will
(a) violate any constitution,  regulation,  rule, injunction,  judgment,  order,
decree,  ruling,  charge, or other  restriction of any government,  governmental
agency,  or court to which the Purchaser is subject or (b) conflict with, result
in a breach of,  constitute  a default  under,  result in the  acceleration  of,
create in any party the right to accelerate,  terminate,  modify,  or cancel, or
require any notice under any agreement, contract, lease, license, instrument, or
other  arrangement  to which the Purchaser is a party or by which it is bound or
to which any of its assets is subject.

4. CONDITIONS OF FIRST CLOSING.

     4.1  The  following  shall  be  conditions  precedent  to  the  Purchaser's
obligations hereunder, and shall be accomplished at or before the first Closing:

          (a) the  representations  and  warranties set forth in Section 2 above
shall  be true and  correct  in all  material  respects  at and as of the  First
Closing Date;

          (b)  Sellers  shall  have  Performed  and  complied  with all of their
covenants hereunder in all material respects through the First Closing; and

          (c) execution and delivery of this Agreement by the Sellers.

     4.2 The following shall be conditions  precedent to the Sellers obligations
hereunder, and shall be accomplished on or before the First Closing:

          (a) the  representations  and  warranties set forth in Section 3 above
shall  be true and  correct  in all  material  respects  at and as of the  First
Closing Date; and

          (b) execution and delivery of this Agreement by the Purchaser; and

                                       -3-
<PAGE>
          (c)  payment  of the  Warrant  Purchase  Price to the  sellers  by the
Purchaser.

     4.3 Each Party may waive any  condition  for its benefit  specified in this
Section 4 by written waiver executed so stating at or prior to the Closing.

5. COVENANTS OF THE SELLERS.

     From and after the date of  execution  hereof,  each Seller  covenants  and
agrees on behalf of itself and any and all  Affiliates (as defined below) of the
Seller, regardless of whether any such Affiliate was an Affiliate at the date of
execution hereof, that it shall not:

          (a) acquire or attempt to acquire any  security of the  Purchaser,  or
any Affiliate of the  Purchaser,  or any interest  therein,  including,  without
limitation,  any share of  stock,  warrant,  option,  debenture,  or  instrument
convertible  into any of the  foregoing,  provided that the parties  acknowledge
that as of the date hereof the Sellers own those Shares set forth on Exhibit A;

          (b) make or participate  in any  solicitation  of proxies  without the
consent of the Purchaser, seek to advise or influence any person with respect to
the voting of any voting securities of the Purchaser, or continue with any proxy
solicitation  that it, or any Affiliate of it, may have  commenced  prior to the
date of execution hereof;

          (c)  form,  join or in any way  participate  in a "group"  within  the
meaning of Section  13(d)(3) of the  Securities  and  Exchange  Act of 1934 with
respect to the voting securities of the Purchaser;

          (d)  induce or attempt  to induce or give  encouragement  to any other
person to initiate any proposal or tender or exchange  offer for any  securities
or change of control of the Purchaser, or

          (e) otherwise  act, alone or in concert with others to seek to control
or influence the management, board of directors or policies of the Purchaser.

For  purposes of this  Agreement,  an  "Affiliate"  shall mean with respect to a
person,   any  person  that  directly,   or  indirectly   through  one  or  more
intermediaries,  controls, or is controlled by, or is under common control with,
such person.

6. POST-CLOSING COVENANTS.

     6.1 Mr.  Blosch  hereby  agrees  that  within  five (5) days of the Sellers
collectively  owning less than 3% of the issued and outstanding shares of Common
Stock of the Company (or shares convertible into Common Stock),  that Mr, Blosch
will  resign as a  director  of the  Purchaser  effective  within  such  period,
provided  that if Mr.  Blosch fails to resign within such period then Mr. Blosch
shall be deemed to have resigned at the end of the such five (5) day period,

     6.2 In the  event  that the  Sellers  collectively  own less than 3% of the
issued  and  outstanding  shares  of  Common  Stock of the  Company  (Or  shares
convertible into Common Stock) then the demand registration rights of Mr. Blosch
and Mr.  Holmes  (together  with any  transferee or assignee of such rights) set
forth in Section 2 of that certain  Registration  Rights  Agreement  between the
Company and  Messrs.  Blosch and  Holmes,  dated as of  February 1, 1998,  shall
immediately terminate without further action of the parties thereto.

                                       -4-
<PAGE>
     6.3 Each of the sellers  hereby  agrees to abstain from voting any of their
shares of common  stock of the  Company at the Annual  Meeting of  Shareholders,
scheduled for June 2, 1999, and any adjournment thereof.

7. RELEASE OF CLAIMS.

     From and after the date of execution hereof:

     7.1  Sellers,   on  behalf  of  themselves  and  each  of  their  partners,
affiliates, associates, agents, representatives,  predecessors,  successors, and
assigns,  past,  present,  and future,  hereby release and forever discharge the
Purchaser  and  each  of  their  respective  Affiliates,   directors,  officers,
employees,   associates,   attorneys,   accountants,   agents,  representatives,
successors,  and  assigns,  past,  present,  and future,  from any and all legal
claims, demands, liens, agreements, contracts, covenants, actions, suits, causes
of  action,  obligations,   controversies,   debts,  costs,  expenses,  damages,
judgments, orders, and liabilities of whatever kind or nature in law, equity, or
otherwise, whether now known or unknown, suspected or unsuspected,  concealed or
hidden, of any kind or nature whatsoever.

     7.2  Purchaser,  on behalf of itself and each of its partners,  affiliates,
associates,  agents,  representatives,  predecessors,  successors,  and assigns,
past,  present,  and future,  hereby releases and forever discharges Sellers and
each of their respective affiliates, associates, attorneys, accountants, agents,
representatives,  successors,  and assigns,  past, present, and future, from any
and all legal claims, demands, liens, agreements, contracts, covenants, actions,
suits, causes of action,  obligations,  controversies,  debts, costs,  expenses,
damages,  judgments,  orders, and liabilities of whatever kind or nature in law,
equity,  or otherwise,  whether now known or unknown,  suspected or unsuspected,
concealed or hidden, of any kind or nature whatsoever.

8. MISCELLANEOUS PROVISIONS.

     8.1 WAIVER OF NOTICE OF BOARD  MEETING.  Mr. Blosch hereby waives notice of
the board of directors meeting of the Purchaser held on May 24, 1999.

     8.2  MODIFICATIONS  AND  WAIVERS.  This  Agreement  may not be  amended  or
modified,  not may the  rights of any party  hereunder  be  waived,  except by a
written document that is executed by the Parties.

     8.3  ASSIGNMENT.  This  Agreement is and shall be binding upon and inure to
the benefit of the parties hereto and their  respective  successors and assigns;
provided, however, that no Purchaser may assign the Agreement to any third party
without the prior written consent of the other Party.

     8.4 RIGHTS AND  OBLIGATIONS  OF THIRD PARTIES.  Nothing in this  Agreement,
whether  express or implied,  is intended to confer any rights or remedies under
or by reason of this  Agreement on any persons  other than the parties to it and
their  respective  successors  and  permitted  assigns,  nor is anything in this
Agreement  intended to relieve or discharge  the  obligation or liability of any
third parties to any party to this  Agreement,  nor shall any provision give any
third  party  any  right of  subrogation  or  action  against  any party to this
Agreement.

     8.5 NOTICES. Any notice, request, consent, or other communication hereunder
shall be in writing,  and shall be sent by one of the  following  means:  (i) by
registered or certified  first class mail,  postage  prepaid;  (ii) by facsimile
transmission;  (iii) by reputable overnight courier service; or (iv) by personal
delivery, and shall be properly addressed as follows:

                                       -5-
<PAGE>
     If to the Purchaser, to:  ZEVEX International, Inc.
                               4314 ZEVEX Park Lane
                               Salt Lake City, Utah 84123
                               Attention: Dean G. Constantine, Chief Executive
                                          Officer
                               Facsimile: (801) 264-1051

     With a copy to:           Jones, Waldo, Holbrook & McDonough
                               1500 Wells Fargo Plaza
                               170 South Main Street
                               Post Office Box 45444
                               Salt Lake City, Utah  84145-0444
                               Attention: Ronald S. Poelman, Esq.
                               Facsimile: (801) 328-0537

     If to the Sellers, to:    To each Seller as set forth on Exhibit A

or to such other  address  or  addresses  as the  Sellers  or  Purchasers  shall
hereafter  designate  to the other party in writing.  Notices sent by mail or by
courier shall be effective three (3) days and one (1) day,  respectively,  after
they are  sent,  and  notices  delivered  Personally  or by  facsimile  shall be
effective at the time of delivery thereof.

     8.6 ENTIRE  AGREEMENT.  This  Agreement,  including  the  Exhibits  hereto,
constitutes the entire  agreement  between the parties hereto in relation to the
matters   contemplated   hereby.   Any  prior  written  or  oral   negotiations,
correspondence,  or understandings  relating to the matters  contemplated hereby
shall be superseded by this Agreement and shall have no force or effect.

     8.7 FURTHER ASSURANCES.  Each Party hereby agrees to take all actions,  and
execute all documents and instruments as either Party deems reasonably necessary
or appropriate to give effect to this Agreement.

     8.8  SEVERABILITY.   If  any  provision  which  is  not  essential  to  the
effectuation  of the basic purpose of this Agreement is determined by a court of
competent jurisdiction to be invalid and contrary to any existing or future law,
such  invalidity  shall not impair the operation of the remaining  provisions of
this Agreement.

     8.9 HEADINGS.  The headings of the Sections of this  Agreement are inserted
for  convenience  of  reference  only and shall not affect the  construction  or
interpretation of any provisions hereof.

     8.10  ARBITRATION.  All disputes  hereunder shall be resolved by mediation,
and if  resolution  is not  reached by the  patties,  then the  dispute  will be
submitted to binding  arbitration  before a single arbitrator in Salt Lake City,
Utah,  in  accordance  with the  applicable  Arbitration  Rules of the  American
Arbitration  Association then in effect. Judgment rendered by the arbitrator may
be entered in any court having jurisdiction over the party.

     8.11  COUNTERPARTS.  This  Agreement  may  be  executed  in any  number  of
counterparts,  each of which when executed and  delivered  shall be an original,
but all of which together shall constitute one and the same instrument.

                                       -6-
<PAGE>
     8.12 GOVERNING LAW. This  Agreement  shall be construed in accordance  with
and  governed  by the laws of the  State of Utah  without  regard  to the law of
conflict of laws.

     IN WITNESS  WHEREOF,  the Company and the Purchasers  each have caused this
Agreement to be executed by their duly authorized  representative  as of the day
and year first above written.

ZEVEX International, Inc.               Sellers


By: /s/ Dean G. Constantine             /s/ Kirk Blosch
    -----------------------------       -----------------------------
    Dean G. Constantine                 Kirk Blosch
    Chief Executive Officer

                                        /s/ Jeff W. Holmes
                                        -----------------------------
                                        Jeff W. Holmes


                                        Blosch & Holmes, LLC


                                        By /s/ Kirk Blosch
                                           --------------------------


                                        Kirk Blosch, Manager
                                        -----------------------------
                                        Print Name/Title

                                       -7-
<PAGE>
                                    EXHIBIT A

                               Shares of
Name                         Warrant Stock     Purchase Price     Warrant Shares
- ----                         -------------     --------------     --------------
Kirk Blosch                     175,000           $437,500            125,000
Jeff W. Holmes                  175,000           $437,500            125,000
Blosch & Holmes, LLC.                                                 250,000


Addresses for Notices:

Kirk Blosch                2081 S. Lakeline Drive
                           Salt Lake City, Utah 84109

Jeff W. Holmes             8800 North Gainey Center Road, Suite 256
                           Scottsdale, AZ 85258

Blosch & Holmes, LLC       2081 S. Lakeline Drive
                           Salt Lake City, Utah 84109

                                       -8-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission